ProPhase Diagnostics

ProPhase Diagnostics, Inc., a wholly owned subsidiary of ProPhase, offers a broad array of clinical diagnostic and testing services at its CLIA certified laboratories including state-of-the-art polymerase chain reaction (PCR) testing for SARS-CoV-2 (COVID-19) and Influenza A and Influenza B. Critical to COVID-19 testing, ProPhase Diagnostics provides fast turnaround times for results. ProPhase Diagnostics also offers best-in-class rapid antigen and antibody/immunity tests to broaden its COVID-19 testing beyond RT-PCR testing. We have announced plans for the expansion of the lab to include traditional clinical testing and genomics testing

Covid testing,pcr testing,rapid antibody and antigen testing,complete covid test offering,fast turnaround times,and two state-of-the-arts labs in ny and nj

Prophase diagnostics operates in the Biotechnology research industry.

Prophase diagnostics's revenue is 11m - 100m

Prophase diagnostics has 11 - 50 employees.